Your browser doesn't support javascript.
loading
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.
Merino-Azpitarte, Maite; Lozano, Elisa; Perugorria, María J; Esparza-Baquer, Aitor; Erice, Oihane; Santos-Laso, Álvaro; O'Rourke, Colm J; Andersen, Jesper B; Jiménez-Agüero, Raúl; Lacasta, Adelaida; D'Amato, Mauro; Briz, Óscar; Jalan-Sakrikar, Nidhi; Huebert, Robert C; Thelen, Kristen M; Gradilone, Sergio A; Aransay, Ana M; Lavín, José L; Fernández-Barrena, Maite G; Matheu, Ander; Marzioni, Marco; Gores, Gregory J; Bujanda, Luis; Marin, José J G; Banales, Jesús M.
Afiliación
  • Merino-Azpitarte M; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Lozano E; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of
  • Perugorria MJ; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain
  • Esparza-Baquer A; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Erice O; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Santos-Laso Á; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • O'Rourke CJ; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Andersen JB; Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Jiménez-Agüero R; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • Lacasta A; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
  • D'Amato M; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  • Briz Ó; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain.
  • Jalan-Sakrikar N; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Huebert RC; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Thelen KM; The Hormel Institute, University of Minnesota, Austin, MN, USA.
  • Gradilone SA; The Hormel Institute, University of Minnesota, Austin, MN, USA.
  • Aransay AM; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain; Genome Analysis Platform, CIC bioGUNE, Bizkaia Technology Park, Derio, Spain.
  • Lavín JL; Genome Analysis Platform, CIC bioGUNE, Bizkaia Technology Park, Derio, Spain.
  • Fernández-Barrena MG; Hepatology Program, CIMA of the University of Navarra, Pamplona, Spain.
  • Matheu A; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain; Neuro-Oncology Group, Biodonostia Research Institute - Donostia University Hospital, San Sebastian, Spain.
  • Marzioni M; Department of Gastroenterology, "Università Politecnica delle Marche", Ancona, Italy.
  • Gores GJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Bujanda L; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain
  • Marin JJG; Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain.
  • Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Spain
J Hepatol ; 67(1): 72-83, 2017 07.
Article en En | MEDLINE | ID: mdl-28237397
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Conductos Biliares / Colangiocarcinoma / Proteínas Supresoras de Tumor / Factores de Transcripción SOXF Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Conductos Biliares / Colangiocarcinoma / Proteínas Supresoras de Tumor / Factores de Transcripción SOXF Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: España